The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Milligan John C.k. Iv since 2014.
This trader's CIK number is 1532230.
At the time of last reporting, Milligan John C.k. Iv was the Secretary/CEO of subsidiary of Therapeuticsmd, Inc.. (stock ticker symbol TXMD).
Also see all insider trading activities at Therapeuticsmd, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | TXMD | 0 | $0 | 44,252 | $46,022 | 103,500 | $0 |
| 2019 | TXMD | 199,000 | $567,500 | 0 | $0 | 0 | $0 |
| 2018 | TXMD | 0 | $0 | 2,032,255 | $10,749,007 | 2,032,255 | $207,289 |
| 2014 | TXMD | 0 | $0 | 403,412 | $2,678,411 | 20,000 | $2,039 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-05-10 | TXMD | Option Ex | 103,500 | .00 | 0 |
| 2021-05-11 | TXMD | Sale | 44,252 | 1.04 | 46,022 |
| 2019-10-25 | TXMD | Buy | 72,000 | 2.75 | 198,000 |
| 2019-10-25 | TXMD | Buy | 72,000 | 2.75 | 198,000 |
| 2019-08-16 | TXMD | Buy | 10,000 | 2.93 | 29,300 |
| 2019-08-12 | TXMD | Buy | 15,000 | 3.16 | 47,400 |
| 2019-08-12 | TXMD | Buy | 15,000 | 3.16 | 47,400 |
| 2019-08-12 | TXMD | Buy | 15,000 | 3.16 | 47,400 |
| 2018-12-17 | TXMD | Option Ex | 129,000 | .10 | 13,158 |
| 2018-12-18 | TXMD | Option Ex | 129,127 | .10 | 13,170 |
| 2018-12-17 | TXMD | Sale | 129,000 | 3.75 | 483,750 |
| 2018-12-18 | TXMD | Sale | 129,127 | 3.64 | 469,634 |
| 2018-12-06 | TXMD | Sale | 129,000 | 4.57 | 589,530 |
| 2018-12-06 | TXMD | Option Ex | 129,000 | .10 | 13,158 |
| 2018-12-04 | TXMD | Sale | 129,000 | 4.98 | 642,162 |
| 2018-12-04 | TXMD | Option Ex | 129,000 | .10 | 13,158 |
| 2018-11-29 | TXMD | Sale | 129,128 | 5.03 | 650,030 |
| 2018-11-29 | TXMD | Option Ex | 129,128 | .10 | 13,171 |
| 2018-11-28 | TXMD | Sale | 129,000 | 4.89 | 630,294 |
| 2018-11-28 | TXMD | Option Ex | 129,000 | .10 | 13,158 |
| 2018-11-14 | TXMD | Option Ex | 129,000 | .10 | 13,158 |
| 2018-11-15 | TXMD | Option Ex | 129,000 | .10 | 13,158 |
| 2018-11-14 | TXMD | Sale | 129,000 | 4.82 | 621,651 |
| 2018-11-15 | TXMD | Sale | 129,000 | 4.99 | 643,581 |
| 2018-10-23 | TXMD | Option Ex | 125,000 | .10 | 12,750 |
| 2018-10-24 | TXMD | Option Ex | 125,000 | .10 | 12,750 |
| 2018-10-23 | TXMD | Sale | 125,000 | 5.33 | 666,250 |
| 2018-10-24 | TXMD | Sale | 125,000 | 5.37 | 671,250 |
| 2018-10-10 | TXMD | Sale | 125,000 | 5.76 | 719,625 |
| 2018-10-10 | TXMD | Option Ex | 125,000 | .10 | 12,750 |
| 2018-10-09 | TXMD | Sale | 125,000 | 5.95 | 743,125 |
| 2018-10-09 | TXMD | Option Ex | 125,000 | .10 | 12,750 |
| 2018-09-25 | TXMD | Sale | 125,000 | 6.78 | 847,250 |
| 2018-09-26 | TXMD | Option Ex | 125,000 | .10 | 12,750 |
| 2018-09-25 | TXMD | Option Ex | 125,000 | .10 | 12,750 |
| 2018-09-26 | TXMD | Sale | 125,000 | 6.78 | 847,000 |
| 2018-09-10 | TXMD | Option Ex | 125,000 | .10 | 12,750 |
| 2018-09-11 | TXMD | Sale | 125,000 | 6.13 | 765,750 |
| 2018-09-10 | TXMD | Sale | 125,000 | 6.07 | 758,125 |
| 2018-09-11 | TXMD | Option Ex | 125,000 | .10 | 12,750 |
| 2014-05-12 | TXMD | Option Ex | 20,000 | .10 | 2,039 |
| 2014-03-26 | TXMD | Sale | 353,412 | 6.70 | 2,366,800 |
| 2014-02-24 | TXMD | Sale | 8,300 | 6.23 | 51,733 |
| 2014-02-25 | TXMD | Sale | 8,300 | 6.16 | 51,119 |
| 2014-02-26 | TXMD | Sale | 8,400 | 6.53 | 54,843 |
| 2014-01-30 | TXMD | Sale | 8,400 | 6.49 | 54,549 |
| 2014-01-28 | TXMD | Sale | 8,300 | 5.94 | 49,318 |
| 2014-01-29 | TXMD | Sale | 8,300 | 6.03 | 50,049 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Milligan John C.k. Iv (Secretary/CEO of subsidiary of Therapeuticsmd, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.